Replication Medical, Inc. designs and develops novel and biomimetic hydrogel implants which provide alternatives to conventional surgical materials. The company produces one product for the US market – EnGuard™ vessel guard, a biocompatible, tissue-like hydrogel that is used to cover spinal blood vessels following anterior vertebral surgery. The company has sales in Europe, but does not yet have FDA approval for US sales.

Categories

Products / Services

Replication medical sells the EnGuard™ Vessel Guard, which is a smooth, soft hydrogel that serves as a protective cover for spinal blood vessels following surgical procedures in the spinal column.

The EnGuard Vessel Guard is made of a proprietary “Hydrogel,” an insoluble hydrophilic polymer with roughly the physical characteristics of cartilage. The surgeon affixes the EnGuard Vessel Guard to surrounding soft tissue or vertebrae using sutures, staples, or tacks.

Replication Medical has two other products - GelFix Interspinous Spacer (back pain) & GelStix Nucleus Augmentation (back pain). These products are sold in Europe but do not have US approval.

Management

Timeline

TIMELINE

Intellectual Property

Crunchbase

LinkedIn

Facebook

Unowned Replication Medical Facebook Page

Twitter

News Feed